My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
about
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
My Pathway: A Study Evaluating ...... nts With Advanced Solid Tumors
@en
type
label
My Pathway: A Study Evaluating ...... nts With Advanced Solid Tumors
@en
prefLabel
My Pathway: A Study Evaluating ...... nts With Advanced Solid Tumors
@en
P4844
P1476
My Pathway: An Open-Label Phas ...... esponse to One of These Agents
@en
P3098
NCT02091141
P580
2014-04-14T00:00:00Z
P582
2020-09-30T00:00:00Z